Uncategorized
Drug Farm Announces FDA Fast Track Designation for First-in-Class ALPK1 Inhibitor DF-003 for the Treatment of ROSAH Syndrome
ALBANY, N.Y. & SHANGHAI--(BUSINESS WIRE)--FDA fast tracks DF-003 for ROSAH syndrome, announces Drug Farm.